Loading... Please wait...

Aridis Pharmaceuticals, Inc. (ARDS) Ownership

Currency in USD Disclaimer
$0.06 $0 (5.26%)
$0.06
$0.07
$0.03
$0.41
  • RECENT QUARTER TOTAL INVESTED

    $10

      -$1,427.00

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    0%

      -0.04%

  • TOTAL INVESTED OF LAST QUARTER

    $1,437
  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    0.04%
*Showing results of the last quarter update as of 12/31/2023

Aridis Pharmaceuticals, Inc. Major Shareholders & Ownership History


Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
02/14/2024 BARTLETT & CO. WEALTH MANAGEMENT LLC 150 $10   100.00% 0.00%
02/14/2024 WEALTH ARCHITECTS, LLC 0 $0   -100.00% 0.00%

Aridis Pharmaceuticals, Inc. institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of ARDS shares?

    A. During the previous two years, 3 institutional investors and hedge funds held shares of Aridis Pharmaceuticals, Inc.. The most heavily invested institutionals were:

    BARTLETT & CO. WEALTH MANAGEMENT LLC: 0

    Minot Wealth Management LLC: 50,000

    B. Riley Wealth Management, Inc.: 10,000

  • Q. What percentage of Aridis Pharmaceuticals, Inc. stock is owned by institutional investors?

    A. 0.00% of Aridis Pharmaceuticals, Inc. stock is owned by institutional investors.

  • Q. How much institutional buying is happening at ARDS ?

    A. Institutional investors have bought a total of 60,000 shares in the last 24 months. This purchase volume represents approximately $3,600 in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.